AXM Pharma, Inc.

Pharmaceutical company awarded 42 drug licenses by Chinese government

Published in Medicine and Law Weekly, December 24th, 2004

AXM Pharma, Inc., (AXJ) announced that the company has received approval from Liaoning FDA and Central FDA for 42 licenses that AXM holds.

Beginning July 1, 2004, all pharmaceutical companies in China were required to obtain national approval licenses to manufacture each of their pharmaceutical products.

In April 2004, AXM submitted applications to renew their licenses, however while pending approval, under law, AXM was not allowed to manufacture or sell any of their drugs.

Forty-two of AXM's pharmaceutical products have now been approved and the commencement of sales can begin.

"We are extremely pleased that...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medicine and Law Weekly

Source: Medicine and Law Weekly (2004-12-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry